Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,682,108 papers from all fields of science
Search
Sign In
Create Free Account
P-glycoprotein Inhibitor
Known as:
P-gp inhibitor
Any compound or agent that acts to prevent the activity of P-glycoprotein.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Spontaneous hemopericardium and cardiac tamponade induced by dabigatran in combination with p-glycoprotein inhibitor
Jose Pascual Salas
,
E. Gaxiola
,
Yara Itzel Tejeda
,
A. Méndez
Journal of Transcatheter Interventions
2019
Corpus ID: 133080587
ABSTRACT Direct oral anticoagulants have been presented as a novel option for prevention and treatment of nonvalvular atrial…
Expand
2015
2015
Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxel.
Kosuke Akiyama
,
N. Maishi
,
+9 authors
K. Hida
American Journal of Pathology
2015
Corpus ID: 23536820
2013
2013
Development of a combinational drug-loaded nanoparticle for improving paclitaxel uptake into multidrug resistant breast cancer cells
Jong-Suep Baek
,
Min-Ho Park
,
Cho-A Lee
,
Eun-Joo Lee
,
C. Cho
2013
Corpus ID: 5030468
SUMMARY Paclitaxel have been used in the treatment of wide range of cancers, but its entry into cancer cell is restricted by p…
Expand
2004
2004
Toxicity of Quinacrine Can Be Reduced By Co-Administration of P-Glycoprotein Inhibitor in Sporadic Creutzfeldt-Jakob Disease
K. Satoh
,
Susumu Shirabe
,
+5 authors
S. Katamine
Cellular and molecular neurobiology
2004
Corpus ID: 12612884
Abstract1. Recent publication has suggested that quinacrine may be a candidate for treatment of Creutzfeldt-Jakob disease (CJD…
Expand
2004
2004
Effect of p-glycoprotein inhibitor combinations on drug efflux from rat brain microvessel endothelial cells.
Z. Yang
,
G. Liu
Pharmazie
2004
Corpus ID: 21207192
In an effort to develop a clinically useful approach to inhibit the drug efflux across the blood brain barrier (BBB) mediated by…
Expand
2004
2004
Effect of p-glycoprotein inhibitor combinations on drug efflux from rat brain microvessel endothelial cells.
Yang Zy
,
Liu Gq
2004
Corpus ID: 89339487
In an effort to develop a clinically useful approach to inhibit the drug efflux across the blood brain barrier (BBB) mediated by…
Expand
2003
2003
Combined treatment of Bcl-2 antisense oligodeoxynucleotides (G3139), p-glycoprotein inhibitor (PSC833), and sterically stabilized liposomal doxorubicin suppresses growth of drug-resistant growth of…
D. E. Lopes de Menezes
,
Yanping Hu
,
L. Mayer
Journal of experimental therapeutics and oncology
2003
Corpus ID: 31520499
We studied the possibility of increasing sensitization of drug-resistant MDA435/LCC6 multidrug-resistant (MDR) human breast…
Expand
2003
2003
The use of p-glycoprotein inhibitor surfactants at the surface of the colloidal carrier
アルフ、ランプレヒト
,
ジャン‐ピエール、ブノワ
2003
Corpus ID: 103353511
Use of a colloidal carrier for the manufacture of a medicament for inhibiting P-glycoprotein, the colloidal carrier is: - a…
Expand
2001
2001
Abundant expression of the microtubule-associated protein, ensconsin (E-MAP-115), alters the cellular response to Taxol.
D. Gruber
,
K. Faire
,
J. Bulinski
Cell Motility and the Cytoskeleton
2001
Corpus ID: 12225305
Correlation between expression level of a microtubule-associated protein called ensconsin (E-MAP-115) and degree of Taxol…
Expand
2000
2000
Contrasting effects of aspirin on prostate cancer cells: Suppression of proliferation and induction of drug resistance
R. Rotem
,
Yifaat Tzivony
,
E. Flescher
The Prostate
2000
Corpus ID: 20230199
Aspirin is widely used as a preventive measure against occlusive vascular diseases. Since the age group in which aspirin use has…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE